A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon

Virology Journal

Richard Njouom²  Mathurin Cyrille Tejiokem¹  Anfumbom KW Kfutwah² 

[1] Epidemiology Service, Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, BP 1274 Yaounde, Cameroon;Virology Service, Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, BP 1274 Yaounde, Cameroon

关键词: Pregnancy;    Cameroon;    HIV;    HBeAg;    HBsAg;    Prevalence;    Hepatitis B virus;   

Others  :  1154919
DOI  :  10.1186/1743-422X-9-62

 received in 2011-09-29, accepted in 2012-03-08,  发布年份 2012

【 摘 要 】

Background

Transmission of hepatitis B virus (HBV) from HBV-positive mothers to their infants is common and usually occurs when the mother is hepatitis B e antigen (HBeAg) positive and/or has a high HBV DNA load. In this study, we determined the prevalence of hepatitis B surface antigen (HBsAg) and HBeAg among pregnant women with known HIV status.

Findings

A total of 650 pregnant women with a mean age of 26.2 years including 301 HIV-positives and 349 HIV-negatives were screened for HBsAg (Monolisa AgHBs Plus Biorad, France). Among the HBsAg-positives, HBeAg and anti-HBe were tested (Monolisa Ag HBe Plus Biorad, France). Overall, 51 (7.85%) were positive for HBsAg. The prevalence of HBsAg was not statistically different between HIV-positive and HIV-negative pregnant women [28/301 (9.3%) vs 23/349 (6.59%); p = 0.2]. None of the 45 HBsAg-positive samples was reactive for HBeAg.

Conclusions

Our study indicates a high prevalence of HBsAg with very low proportion of HBeAg in Cameroonian pregnant women. Since perinatal transmission of HBV is mostly effective when the mother is also HBeAg-positive, our data could suggest that perinatal transmissions play a minor role in HBV prevalence in Cameroon. In line with previous African studies, these findings further suggests that horizontal transmission could be the most common mechanism of HBV infections in Cameroon.

【 授权许可】

   
2012 Kfutwah et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Lok AS: Chronic hepatitis B. N Engl J Med 2002, 346(22):1682-1683.
• [2]Guntupalli SR, Steingrub J: Hepatic disease and pregnancy: an overview of diagnosis and management. Crit Care Med 2005, 33(10 Suppl):S332-S339.
• [3]Broderick AL, Jonas MM: Hepatitis B in children. Semin Liver Dis 2003, 23(1):59-68.
• [4]Wang Z, Zhang J, Yang H, Li X, Wen S, Guo Y, Sun J, Hou J: Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003, 71(3):360-366.
• [5]del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, de Gast GC, Fetter WP, Zwijneberg J, Schalm SW: Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997, 15(15):1624-1630.
• [6]Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG: Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998, 27(1):100-106.
• [7]Lee C, Gong Y, Brok J, Boxall EH, Gluud C: Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006, 332(7537):328-336.
• [8]Ayouba A, Tene G, Cunin P, Foupouapouognigni Y, Menu E, Kfutwah A, Thonnon J, Scarlatti G, Monny-Lobé M, Eteki N, Kouanfack C, Tardy M, Leke R, Nkam M, Nlend AE, Barré-Sinoussi F, Martin PM, Nerrienet E: Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaoundé, Cameroon. J Acquir Immune Defic Syndr 2003, 34(3):274-280.
• [9]Njouom R, Pasquier C, Ayouba A, Tejiokem MC, Vessiere A, Mfoupouendoun J, Tene G, Eteki N, Lobe MM, Izopet J, Nerrienet E: 2 Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am J Trop Med Hyg 2005, 73(2):460-466.
• [10]Ndumbe PM, Skalsky J, Joller-Jemelka HI: Seroprevalence of hepatitis and HIV infection among rural pregnant women in Cameroon. APMIS 1994, 102(9):662-666.
• [11]Ndumbe PM, Njie TK: Hepatitis A and B infections in Yaoundé, Cameroon. Res Virol 1989, 140(3):253-261.
• [12]Chiaramonte M, Stroffolini T, Ngatchu T, Rapicetta M, Lantum D, Kaptue L, Chionne P, Conti S, Sarrecchia B, Naccarato R: Hepatitis B virus infection in Cameroon: a seroepidemiological survey in city school children. J Med Virol 1991, 33(2):95-99.
• [13]McIntosh ED, Bek MD, Cardona M, Goldston K, Isaacs D, Burgess MA, Cossart YE: Horizontal transmission of hepatitis B in a children's day-care centre: a preventable event. Aust N Z J Public Health 1997, 21(7):791-792.
• [14]Goudeau A, Yvonnet B, Lesage G, Barin F, Denis F, Coursaget P, Chiron JP, Diop Mar I: Lack of anti-HBc IgM in neonates with HBsAg carrier mothers argues against transplacental transmission of hepatitis B virus infection. Lancet 1983, 2(8359):1103-1104.
• [15]Whittle HC, Bradley AK, McLauchlan K, Ajdukiewicz AB, Howard CR, Zuckerman AJ, McGregor IA: Hepatitis B virus infection in two Gambian villages. Lancet 1983, 1(8335):1203-1206.
• [16]Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, Leroy V, Dabis F, Rouzioux C: HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study. J Med Virol 2004, 74(1):34-40.
• [17]Jacobs B, Mayaud P, Changalucha J, Todd J, Ka-Gina G, Grosskurth H, Berege ZA: Sexual transmission of hepatitis B in Mwanza, Tanzania. Sex Transm Dis 1997, 24(3):121-126.
• [18]Zhang X, Xing Y, Shen L: Follow-up on hepatitis B immunized neonates born to HBsAg positive mothers. Zhonghua Yu Fang Yi Xue Za Zhi 1998, 32(2):97-99.
• [19]Kew MC, Kassianides C, Berger EL, Song E, Dusheiko GM: Prevalence of chronic hepatitis B virus infection in pregnant black women living in Soweto. J Med Virol 1987, 22(3):263-268.
• [20]Menendez C, Sanchez-Tapias JM, Kahigwa E, Mshinda H, Costa J, Vidal J, Acosta C, Lopez-Labrador X, Olmedo E, Navia M, Tanner M, Rodes J, Alonso PL: Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999, 58(3):215-220.
• [21]Marinier E, Barrois V, Larouze B, London WT, Cofer A, Diakhate L, Blumberg BS: Lack of perinatal transmission of hepatitis B virus infection in Senegal, West Africa. J Pediatr 1985, 106(5):843-849.
• [22]Roingeard P, Diouf A, Sankale JL, Boye C, Mboup S, Diadhiou F, Essex M: Perinatal transmission of hepatitis B virus in Senegal, west Africa. Viral Immunol 1993, 6(1):65-73.
• [23]Chu CJ, Hussain M, Lok AS: Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002, 36(6):1408-1415.
• [24]Kao JH, Chen PJ, Lai MY, Chen DS: Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J Clin Microbiol 2002, 40(1):22-25.
• [25]Candotti D, Opare-Sem O, Rezvan H, Sarkodie F, Allain JP: Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase. J Viral Hepat 2006, 13(11):715-724.